http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2574340-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497
filingDate 2007-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a4d7b76d854221991fc40b7a58f2494
publicationDate 2013-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2574340-A3
titleOfInvention Combination comprising a pyrimidylaminobenzamide compound and a THR315LLEe kinase inhibitor
abstract The invention provides a pharmaceutical combination: a) a pryrimidylaminobenzamide compound, and b) a Thr315lle kinase inhibitor and a method for treating or preventing a proliferative disease using such a combination.
priorityDate 2006-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004026234-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006003384-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004005281-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007056023-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03020252-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03047523-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226656020
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248128933
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23651250

Total number of triples: 31.